Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Long-Term Deferred Tax (2020 - 2025)

Beauty Health (SKIN) has disclosed Long-Term Deferred Tax for 6 consecutive years, with $985000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Deferred Tax fell 15.96% to $985000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $985000.0, a 15.96% decrease, with the full-year FY2024 number at $3.9 million, up 633.33% from a year prior.
  • Long-Term Deferred Tax was $985000.0 for Q3 2025 at Beauty Health, down from $3.2 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $4.3 million in Q1 2025 to a low of $268000.0 in Q3 2022.
  • A 5-year average of $1.4 million and a median of $823000.0 in 2022 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: plummeted 73.93% in 2022, then skyrocketed 633.33% in 2024.
  • Beauty Health's Long-Term Deferred Tax stood at $330000.0 in 2021, then skyrocketed by 146.97% to $815000.0 in 2022, then plummeted by 34.85% to $531000.0 in 2023, then surged by 633.33% to $3.9 million in 2024, then tumbled by 74.7% to $985000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Long-Term Deferred Tax are $985000.0 (Q3 2025), $3.2 million (Q2 2025), and $4.3 million (Q1 2025).